about
In very young infants severity of acute bronchiolitis depends on carried virusesEpidemiology and etiology of childhood pneumoniaGlucocorticoids for acute viral bronchiolitis in infants and young childrenGlucocorticoids for acute viral bronchiolitis in infants and young childrenPharmacological management of acute bronchiolitisRespiratory syncytial virus induces prostaglandin E2, IL-10 and IL-11 generation in antigen presenting cellsEffectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Children: A Real-World PerspectiveThe use of humanized monoclonal antibodies for the prevention of respiratory syncytial virus infectionImpact of respiratory syncytial virus: the nurse's perspectiveChemR23 dampens lung inflammation and enhances anti-viral immunity in a mouse model of acute viral pneumoniaImplication of the proprotein convertases furin, PC5 and PC7 in the cleavage of surface glycoproteins of Hong Kong, Ebola and respiratory syncytial viruses: a comparative analysis with fluorogenic peptidesThe synthetic bacterial lipopeptide Pam3CSK4 modulates respiratory syncytial virus infection independent of TLR activationInfluenza and respiratory syncytial virus in infants study (IRIS) of hospitalized and non-ill infants aged <1 year in four countries: study design and methodsGlobal burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysisInnate immunity proteins and a new truncated form of SPLUNC1 in nasopharyngeal aspirates from infants with respiratory syncytial virus infection.Comparing pandemic to seasonal influenza mortality: moderate impact overall but high mortality in young children.Nanodiscs as a therapeutic delivery agent: inhibition of respiratory syncytial virus infection in the lung.A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33-35 weeks of gestational age, based on data from the Spanish FLIP Study.NGF is an essential survival factor for bronchial epithelial cells during respiratory syncytial virus infection.Cost effectiveness of palivizumab in Spain: an analysis using observational data.Duration of shedding of respiratory syncytial virus in a community study of Kenyan childrenOutcomes of palivizumab prophylaxis for respiratory syncytial virus infection in preterm children with bronchopulmonary dysplasia at a single hospital in Korea from 2005 to 2009.Respiratory syncytial virus disease in preterm infants in the U.S. born at 32-35 weeks gestation not receiving immunoprophylaxis.Bacterial lysates improve the protective antibody response against respiratory viruses through Toll-like receptor 4.Early-life viral infection and allergen exposure interact to induce an asthmatic phenotype in miceInfluenza and other respiratory virus infections in outpatients with medically attended acute respiratory infection during the 2011-12 influenza season.Pharmacologic advances in the treatment and prevention of respiratory syncytial virus.Viral lower respiratory tract infection in infants and young children.A novel six consecutive monthly doses of palivizumab prophylaxis protocol for the prevention of respiratory syncytial virus infection in high-risk preterm infants in Taiwan.Respiratory syncytial virus infections in infants affected by primary immunodeficiency.A frequentist approach to estimating the force of infection for a respiratory disease using repeated measurement data from a birth cohortActivation of lymphocytes induced by bronchial epithelial cells with prolonged RSV infection.Pharmacokinetics-pharmacodynamics of a respiratory syncytial virus fusion inhibitor in the cotton rat model.Human metapneumovirus infections in hospitalized children.Identification of immunodominant epitopes derived from the respiratory syncytial virus fusion protein that are recognized by human CD4 T cells.Food intake during the previous 24 h as a percentage of usual intake: a marker of hypoxia in infants with bronchiolitis: an observational, prospective, multicenter studyRespiratory syncytial virus infection-associated hospitalization in adults: a retrospective cohort study.Mechanical ventilation drives inflammation in severe viral bronchiolitis.Comparison of risk factors between preterm and term infants hospitalized for severe respiratory syncytial virus in the Russian Federation.Intranasal administration of maleic anhydride-modified human serum albumin for pre-exposure prophylaxis of respiratory syncytial virus infection
P2860
Q21143862-CAB2D997-FA38-4051-AD3E-AE63D224018BQ22241278-3D68F86A-C02F-47BA-89FC-B233BFA28C3BQ24243330-2969D859-44FE-4675-8321-2E0D871A79D9Q24246721-A561C7F4-0DA5-4B3A-A6C4-A66A5F1DC3A9Q24650574-467C31DF-5B28-4F55-B508-024A3AD11273Q24681094-FC382B4F-9583-415E-8A31-DF02A577EC7EQ26830864-3834921C-BF9A-475A-AC82-5F9E2786DBFDQ26864494-D2594EEE-BD3F-4614-ADAE-540BA04AAF55Q27023799-F077B5BC-F8A6-4C0F-84A8-AFC26A73A47BQ27348572-A4BD62BD-6EA5-4C60-8833-71AC2714A1CCQ28347718-524841D4-D05F-40FE-A3E3-1C1A203D4CAFQ28749631-53273E99-7247-4644-9F0D-0AE2C0A020BDQ29248088-189502B0-7122-4B54-9EB9-8DBE8EFB7983Q29619821-34519597-B99D-46C6-A3D5-F4AABB2179A2Q29871455-0E648460-C457-4171-AF45-549E2D1431F9Q30412819-E747DB2F-8A82-4ACC-9584-FE946B63D265Q30431169-EC040A89-392A-4510-B9C6-B3F1BF88C978Q33390780-EAA8183F-C26A-4C19-8FC0-BA13D396A36CQ33489541-4F9F3DCE-B69E-4B35-AD0B-D41621D95774Q33517462-21E79A7F-62B0-412A-BD1D-D33B2BE3893AQ33526047-6D2F1679-CE7E-4147-ACC3-83957965219EQ33610003-D2FE0F33-3C75-4622-B956-3B0075C6C9F0Q33630047-045E2394-0E25-4C11-8036-455C53AEE9DFQ33723524-568B8563-AB9C-4506-BD38-047480B06C3FQ33741672-FB4AA18B-895A-432F-9410-349F45AF2BF7Q33756909-87FDC548-F080-47EE-908C-4BC3AA0734CAQ33776507-B59968C2-4818-471A-8E0D-C723B856F872Q33815604-1CB9ED8A-63BD-492D-9A6F-5E78046BAA2FQ33817471-7801159A-BF12-422E-8B55-185F8FF6B8E1Q33892605-075D8586-E60B-4419-A7C7-99D214E9BF65Q34057956-B87D8A64-E53B-411F-8F68-3AF4DE81F8E8Q34116896-CC22B832-F628-4049-A5B7-F750CA0030ACQ34290125-346BAFED-7F07-4429-B7AE-E9551E502018Q34396426-EFEFD669-CA31-4BF3-BD34-F2891009F6DEQ34465367-A3CC718C-93FE-46E3-B162-C59FC872216CQ34545979-C1FF296B-2829-4BAA-A90D-B364A918B96AQ34728523-614C2B8B-4438-4F95-A915-7388E6F21705Q35070732-410C91E3-17BD-4D9A-B9B2-8561DDF3F9DBQ35119631-F7540C89-6399-413C-892D-7D13DB89C600Q35160026-A4007911-324B-4636-892D-1D98A2EDFBB2
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Respiratory syncytial virus infection.
@ast
Respiratory syncytial virus infection.
@en
type
label
Respiratory syncytial virus infection.
@ast
Respiratory syncytial virus infection.
@en
prefLabel
Respiratory syncytial virus infection.
@ast
Respiratory syncytial virus infection.
@en
P1433
P1476
Respiratory syncytial virus infection.
@en
P2093
E A Simoes
P304
P356
10.1016/S0140-6736(99)80040-3
P407
P577
1999-09-01T00:00:00Z